Prediction of warfarin dose: why, when and how?
Related Experiment Video
Updated: May 24, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Niclas Eriksson1, Mia Wadelius
1Department of Medical Sciences, Clinical Pharmacology, Uppsala University, Uppsala University Hospital, entrance 61, SE-751 85 Uppsala, Sweden. niclas.eriksson@ucr.uu.se
Abstract:
Prediction models are the key to individualized drug therapy. Warfarin is a typical example of where pharmacogenetics could help the individual patient by modeling the dose, based on clinical factors and genetic variation in CYP2C9 and VKORC1. Clinical studies aiming to show whether pharmacogenetic warfarin dose predictions are superior to conventional initiation of warfarin are now underway. This review provides a broad view over the field of warfarin pharmacogenetics from basic knowledge about the drug, how it is monitored, factors affecting dose requirement, prediction models in general and different types of prediction models for warfarin dosing.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care
Dosage Regimen: Multiple Oral Dosage
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Therapeutic Drug Monitoring: Affecting Factors
Pharmacogenetics of Drug Metabolism: Overview